Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$0.38 - $0.76 $3,028 - $6,057
-7,970 Reduced 20.85%
30,251 $12,000
Q2 2023

Aug 11, 2023

BUY
$0.68 - $12.39 $5,498 - $100,185
8,086 Added 26.83%
38,221 $26,000
Q1 2023

May 15, 2023

BUY
$0.9 - $7.89 $1,834 - $16,079
2,038 Added 7.25%
30,135 $237,000
Q1 2022

May 13, 2022

SELL
$1.82 - $3.24 $15,129 - $26,934
-8,313 Reduced 22.83%
28,097 $66,000
Q4 2021

Feb 08, 2022

SELL
$2.36 - $4.05 $573 - $984
-243 Reduced 0.66%
36,410 $113,000
Q3 2021

Nov 15, 2021

BUY
$3.75 - $4.86 $367 - $476
98 Added 0.27%
36,653 $149,000
Q2 2021

Aug 13, 2021

SELL
$3.83 - $5.65 $149,461 - $220,485
-39,024 Reduced 51.63%
36,555 $177,000
Q1 2021

May 12, 2021

SELL
$5.07 - $8.27 $71,121 - $116,011
-14,028 Reduced 15.66%
75,579 $393,000
Q4 2020

Feb 11, 2021

SELL
$6.12 - $10.37 $16,028 - $27,159
-2,619 Reduced 2.84%
89,607 $598,000
Q3 2020

Nov 16, 2020

BUY
$9.27 - $13.79 $19,847 - $29,524
2,141 Added 2.38%
92,226 $938,000
Q2 2020

Aug 14, 2020

BUY
$9.43 - $20.28 $849,501 - $1.83 Million
90,085 New
90,085 $1.13 Million

Others Institutions Holding BLPH

# of Institutions
1
Shares Held
44K
Call Options Held
0
Put Options Held
0

About Bellerophon Therapeutics, Inc.


  • Ticker BLPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,545,450
  • Market Cap $95.5K
  • Description
  • Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...
More about BLPH
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.